» Authors » Taishi Yonetsu

Taishi Yonetsu

Explore the profile of Taishi Yonetsu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 250
Citations 2436
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hanyu Y, Hoshino M, Usui E, Sugiyama T, Kanaji Y, Hada M, et al.
Catheter Cardiovasc Interv . 2025 Mar; PMID: 40079638
Background: Limited research has explored the prognostic significance of changes in coronary flow velocity reserve (CFVR), as measured by stress-transthoracic Doppler echocardiography (S-TDE), following elective percutaneous coronary intervention (PCI). This...
2.
Yamaguchi M, Fujii H, Suzuki H, Shimizu M, Hoshino M, Usui E, et al.
Sci Rep . 2025 Mar; 15(1):8530. PMID: 40074855
Although studies have reported various patterns of atherosclerotic aortic plaques (AAPs) detected by non-obstructive aortic angioscopy (NOA), the long-term outcomes associated with AAPs such as puff-chandelier rupture atheromatous plaque (PCR),...
3.
Ikuta A, Yajima J, Okazaki S, Yonetsu T, Ando J, Takamisawa I, et al.
J Cardiol . 2025 Feb; PMID: 39909305
Background: Owing to the advent of new generation drug-eluting stents, percutaneous coronary intervention (PCI) outcomes are improving. However, the polymers, which have been the most common type of coatings used...
4.
Matsuda Y, Yonetsu T, Kurihara K, Shimizu S, Ueshima D, Inagaki H, et al.
J Cardiol . 2025 Jan; PMID: 39842693
Background: Excimer laser coronary atherectomy (ELCA) is used for thrombotic culprit lesions in ST-segment elevation myocardial infarction (STEMI), but its effectiveness is still unclear. Methods: Consecutive patients undergoing primary percutaneous...
5.
Hada M, Usui E, Wakasa N, Hoshino M, Kanaji Y, Nagamine T, et al.
Hellenic J Cardiol . 2024 Dec; PMID: 39672538
Objective: Epicardial stenosis and coronary microvascular dysfunction (CMD) may coexist in patients with chronic coronary syndrome (CCS). Microvascular resistance reserve (MRR) has been demonstrated to be a valid cross-modality metric...
6.
Misawa T, Lee T, Ashikaga T, Nozato T, Yonetsu T, Sasano T
Front Cardiovasc Med . 2024 Dec; 11:1470785. PMID: 39624219
In patients undergoing percutaneous coronary intervention (PCI), severely calcified lesions remain a great challenge even in the drug-eluting stent (DES) era. Intravascular lithotripsy (IVL) is effective for modification of severely...
7.
Ueno H, Usui E, Hoshino M, Kanaji Y, Sugiyama T, Hada M, et al.
Sci Rep . 2024 Nov; 14(1):28393. PMID: 39551834
Coronary flow capacity (CFC) integrates quantitative assessment of hyperemic myocardial blood flow and coronary flow reserve. We aimed to evaluate the effect of elective percutaneous coronary revascularization (PCI) on CFC...
8.
Tian J, Li C, Qin Z, Zhang Y, Xu Q, Zheng Y, et al.
Biomed Opt Express . 2024 Sep; 15(8):4438-4452. PMID: 39347010
Coronary artery calcification (CAC) is a marker of atherosclerosis and is thought to be associated with worse clinical outcomes. However, evidence from large-scale high-resolution imaging data is lacking. We proposed...
9.
Niida T, Usui E, Suzuki K, Kinoshita D, Yuki H, Fujimoto D, et al.
J Cardiovasc Comput Tomogr . 2024 Sep; 18(6):568-574. PMID: 39322513
Backgrounds: Coronary computed tomography angiography (CTA) allows for the assessment of atherosclerotic plaque burden across the entire coronary vasculature. No studies have examined the relationship between the underlying pathology of...
10.
Yoshikawa H, Sugiyama T, Araki M, Yonetsu T, Sasano T
Eur Heart J Case Rep . 2024 Aug; 8(8):ytae421. PMID: 39176023
Background: Coronary stents have been reported to cause endothelial dysfunction, potentially leading to spasm at the edges of the stent. However, the clinical significance of vascular spasm in stent-jailed side...